About
Research
Patient Care
Education
Community
Aug 16, 2023
UC Irvine-led study links low-dose radiation to higher cancer risk
“We wanted to strengthen the scientific basis for radiation protection by directly studying settings where low-dose exposures occur,” said corresponding author David Richardson, Ph.D., professor of environmental and occupational health with UCI’s Program in Public Health. “Understanding those associations is essential to inform decisions about medical and commercial uses of ionizing radiation, exposure limits for the public, and workers.”
Aug 01, 2023
Associate Professor Claudia Benavente featured on Chilean TV show
Claudia Benavente, UCI associate professor of pharmaceutical sciences, was recently featured on the Chilean TV show “Pasaporte Ciencia” (“Science Passport”) as one of the Chilean scientists conducting important research in various countries around the world. The host, Cristian Hernandez, and his team traveled to campus for the interview. “The initial challenge for the production was to prove they could create a show with gender parity, and I immediately saw the value in the opportunity to bring science closer to the average person,” Benavente said. “The show touches on our experiences from training to the work we currently do, which, in my case, is searching for cures for childhood cancer.”
Jul 24, 2023
Bridging the Gap: Latinx Children with Cancer, Culturally Appropriate Support for Families
Fortier’s work has shown that the pain management treatment of Latinx children – and their outcomes – are too often inadequate when compared to non-Latinx white children. Besides the immediate impact of not assisting a child in need, researchers have found that there are long term consequences to poorly managed pain that amplify health inequities for Latinx patients when they are adults including changes in their physiological responses to pain and avoidance of preventive healthcare to support wellness.
Jun 22, 2023
Breakthroughs offer hope for vitiligo patients
In 2018, Dr. Anand K. Ganesan (above left) opened a vitiligo specialty practice lab at the UCI Health Beckman Laser Institute & Medical Clinic, hoping to find new therapies to reverse the disfiguring skin disorder. Now, the lab has produced a topical cream called ruxolitinib, the first therapy approved by the U.S. Federal Drug Administration that restores pigment in vitiligo patients. The FDA also recently gave breakthrough device approval for RECELL®, a one-time therapy using the patient’s healthy cells to stimulate lasting repigmentation in stable vitiligo.
Jun 08, 2023
UC Irvine study finds that lesbian, gay and bisexual cancer survivors experience more health-related challenges compared to heterosexual counterparts
Public health researchers from the University of California, Irvine have determined that lesbian, gay and bisexual cancer survivors experience a lower quality of life compared to their heterosexual counterparts, specifically in the mental and social aspects of their overall health. Corresponding author Michael Hoyt, PhD, associate professor of population health and disease prevention from UCI’s Program in Public Health, and his collaborators published their findings in the Journal of Psychosocial Oncology.
May 30, 2023
Courageous Corazones
A pilot intervention is helping Latinx families care for their children with cancer. Corazones Unidos Por Una Vida (Hearts United for Life) is a prototype program of support for Latinx families with children who are undergoing cancer treatment at Children’s Hospital of Orange County. It is designed and driven by Associate Professor Michelle Fortier, a clinical psychologist and pediatric pain expert at the Sue & Bill Gross School of Nursing and UCI Center on Stress and Health. Fortier is also a CFCCC member.
May 25, 2023
Celebrating decades long UC Irvine legacy and impact on cancer research & public health interventions
Professor of population health and disease prevention and general internal medicine – Lari Wenzel, PhD, from the UCI Program in Public Health and the School of Medicine, is retiring at the end of June after 27 years of campus service. She leaves an outstanding legacy of achievements and a portfolio of valuable cancer research. Her contributions to the public health field are truly remarkable and her impact on countless students, faculty, and communities around the nation cannot be overstated.
May 02, 2023
Cancer Control Members receive School of Medicine New Investigator Faculty Research Grant
Drs. Jacqueline Kim, Sunmin Lee, and Edward Kuan, Cancer Control Members, receive School of Medicine New Investigator Faculty Research Grant. The overall goal of this funding mechanism is to help early-stage investigators in the School of Medicine obtain extramural funding and to promote collaborative interdisciplinary research.
Apr 25, 2023
Shawn Griffin Receives 2023 HOPA Early Career Research Grant
Shawn Griffin, health sciences assistant clinical professor, at the UC Irvine School of Pharmacy & Pharmaceutical Sciences, has received a 2023 Hematology/Oncology Pharmacy Association Early Career Research Grant. The grant will fund a correlative pharmacokinetic study to the ADAPT trial (principal investigator Stefan Ciurea from the UCI School of Medicine) that is about to open at the UCI Chao Family Comprehensive Cancer Center for patients undergoing hematopoietic stem cell transplantation.
Apr 24, 2023
Getting better results with “GET” therapy for young adult testicular cancer survivors
Associate professor of population health and disease prevention, Michael Hoyt, PhD, developed new behavioral therapy that he and his collaborators suggest could provide much needed support to young adult testicular cancer survivors. Their research is published in the journal Annals of Behavioral Medicine.